{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:30:04Z","timestamp":1754163004282,"version":"3.41.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"DOI":"10.7759\/cureus.89081","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:00:18Z","timestamp":1753916418000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Impact of All-Trans Retinoic Acid (ATRA)- and Arsenic Trioxide (ATO)-Based Therapy in Pediatric Acute Promyelocytic Leukemia: A Single-Center Study"],"prefix":"10.7759","author":[{"given":"Reshma","family":"Roshan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubashir  H","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherook","family":"J","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidel F","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javid R","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-202192","article-title":"Epidemiology and survival outcomes of acute promyelocytic leukemia in adults: a SEER database analysis","volume":"144","author":"Ali H","year":"2024","unstructured":"Ali H, Durugu SR, Agrawal S, et al.. Epidemiology and survival outcomes of acute promyelocytic leukemia in adults: a SEER database analysis. Blood. 2024, 144:5943. 10.1182\/blood-2024-202192","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.3.759","article-title":"Acute promyelocytic leukemia: evolving therapeutic strategies","volume":"99","author":"Tallman MS","year":"2002","unstructured":"Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 2002, 99:759-67. 10.1182\/blood.v99.3.759","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2014.09.013","article-title":"Global characteristics of childhood acute promyelocytic leukemia","volume":"29","author":"Zhang L","year":"2015","unstructured":"Zhang L, Samad A, Pombo-de-Oliveira MS, et al.. Global characteristics of childhood acute promyelocytic leukemia. Blood Rev. 2015, 29:101-25. 10.1016\/j.blre.2014.09.013","journal-title":"Blood Rev"},{"key":"ref4","unstructured":"Acute promyelocytic leukemia. (2025). Accessed. April 8, 2025: https:\/\/medlineplus.gov\/genetics\/condition\/acute-promyelocytic-leukemia\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27513","article-title":"Acute promyelocytic leukemia (APL): a review of the literature","volume":"11","author":"Jimenez JJ","year":"2020","unstructured":"Jimenez JJ, Chale RS, Abad AC, Schally AV. Acute promyelocytic leukemia (APL): a review of the literature. Oncotarget. 2020, 11:992-1003. 10.18632\/oncotarget.27513","journal-title":"Oncotarget"},{"key":"ref6","article-title":"Acute promyelocytic leukemia: morphological aspects","volume":"8","author":"Castoldi GL","year":"1994","unstructured":"Castoldi GL, Liso V, Specchia G, Tomasi P. Acute promyelocytic leukemia: morphological aspects. Leukemia. 1994, 8:1441-6.","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4081\/cp.2011.e11","article-title":"Acute promyelocytic leukemia, hypogranular variant: a rare presentation","volume":"1","author":"Akhtar K","year":"2011","unstructured":"Akhtar K, Ahmad S, Sherwani RK. Acute promyelocytic leukemia, hypogranular variant: a rare presentation. Clin Pract. 2011, 1:e11. 10.4081\/cp.2011.e11","journal-title":"Clin Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00514-3","article-title":"Acute promyelocytic leukemia current treatment algorithms","volume":"11","author":"Yilmaz M","year":"2021","unstructured":"Yilmaz M, Kantarjian H, Ravandi F. Acute promyelocytic leukemia current treatment algorithms. Blood Cancer J. 2021, 11:123. 10.1038\/s41408-021-00514-3","journal-title":"Blood Cancer J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.586004","article-title":"Therapeutic approaches for acute promyelocytic leukaemia: moving towards an orally chemotherapy-free era","volume":"10","author":"Xu ZL","year":"2020","unstructured":"Xu ZL, Huang XJ. Therapeutic approaches for acute promyelocytic leukaemia: moving towards an orally chemotherapy-free era. Front Oncol. 2020, 10:586004. 10.3389\/fonc.2020.586004","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2991\/chi.k.210703.001","article-title":"History of acute promyelocytic leukemia","volume":"3","author":"Sanz MA","year":"2021","unstructured":"Sanz MA, Barrag\u00e1n E. History of acute promyelocytic leukemia. Clin Hematol Int. 2021, 3:142-52. 10.2991\/chi.k.210703.001","journal-title":"Clin Hematol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101591","article-title":"Acute promyelocytic leukemia: update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies","volume":"11","author":"Noguera NI","year":"2019","unstructured":"Noguera NI, Catalano G, Banella C, et al.. Acute promyelocytic leukemia: update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies. Cancers (Basel). 2019, 11:10.3390\/cancers11101591","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90001-0","article-title":"Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors","volume":"38","author":"Awisati G","year":"2001","unstructured":"Awisati G, Lo Coco F, Mandelli F. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors. Semin Hematol. 2001, 38:4-12. 10.1016\/S0037-1963(01)90001-0","journal-title":"Semin Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280093","article-title":"A risk score based on real-world data to predict early death in acute promyelocytic leukemia","volume":"107","author":"\u00d6sterroos A","year":"2022","unstructured":"\u00d6sterroos A, Maia T, Eriksson A, et al.. A risk score based on real-world data to predict early death in acute promyelocytic leukemia. Haematologica. 2022, 107:1528-37. 10.3324\/haematol.2021.280093","journal-title":"Haematologica"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco F","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, et al.. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013, 369:111-21. 10.1056\/NEJMoa1300874","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1007\/s13312-022-2622-2","article-title":"Diagnosis, treatment and prevention of nutritional anemia in children: recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics","volume":"59","author":"Chandra J","year":"2022","unstructured":"Chandra J, Dewan P, Kumar P, et al.. Diagnosis, treatment and prevention of nutritional anemia in children: recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics. Indian Pediatr. 2022, 59:782-801.","journal-title":"Indian Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.31557\/apjcc.2021.6.4.383-387","article-title":"Acute promyelocytic leukemia: simplifying treatment in a resource poor setting","volume":"6","author":"Bhise R","year":"2021","unstructured":"Bhise R, Ahmed I, Imtiaz S. Acute promyelocytic leukemia: simplifying treatment in a resource poor setting. Asian Pac J Cancer Care. 2021, 6:383-7. 10.31557\/apjcc.2021.6.4.383-387","journal-title":"Asian Pac J Cancer Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830070412","article-title":"Acute promyelocytic leukemia","volume":"7","author":"Groopman J","year":"1979","unstructured":"Groopman J, Ellman L. Acute promyelocytic leukemia. Am J Hematol. 1979, 7:395-408. 10.1002\/ajh.2830070412","journal-title":"Am J Hematol"},{"key":"ref18","unstructured":"Acute promyelocytic leukaemia (APL). (2025). Accessed. April 1, 2025: https:\/\/www.cancerresearchuk.org\/about-cancer\/acute-myeloid-leukaemia-aml\/types-aml\/acute-promyelocytic-leukaemia."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071237","article-title":"An end-to-end pipeline for early diagnosis of acute promyelocytic leukemia based on a compact CNN model","volume":"11","author":"Qiao Y","year":"2021","unstructured":"Qiao Y, Zhang Y, Liu N, Chen P, Liu Y. An end-to-end pipeline for early diagnosis of acute promyelocytic leukemia based on a compact CNN model. Diagnostics (Basel). 2021, 11:10.3390\/diagnostics11071237","journal-title":"Diagnostics (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168617","article-title":"Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors","volume":"113","author":"Montesinos P","year":"2009","unstructured":"Montesinos P, Bergua JM, Vellenga E, et al.. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009, 113:775-83. 10.1182\/blood-2008-07-168617","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.10","article-title":"Acute promyelocytic leukemia: preventing early complications and late toxicities","volume":"2016","author":"Abedin S","year":"2016","unstructured":"Abedin S, Altman JK. Acute promyelocytic leukemia: preventing early complications and late toxicities. Hematology Am Soc Hematol Educ Program. 2016, 2016:10-5. 10.1182\/asheducation-2016.1.10","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.577796","article-title":"Hypertriglyceridemia in newly diagnosed acute promyelocytic leukemia","volume":"10","author":"Sun J","year":"2020","unstructured":"Sun J, Lou Y, Zhu J, et al.. Hypertriglyceridemia in newly diagnosed acute promyelocytic leukemia. Front Oncol. 2020, 10:577796. 10.3389\/fonc.2020.577796","journal-title":"Front Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2014105","article-title":"Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centre","volume":"55","author":"Karim F","year":"2014","unstructured":"Karim F, Shaikh U, Adil SN, Khurshid M. Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centre. Singapore Med J. 2014, 55:443-7. 10.11622\/smedj.2014105","journal-title":"Singapore Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386763-assessing-the-impact-of-all-trans-retinoic-acid-atra--and-arsenic-trioxide-ato-based-therapy-in-pediatric-acute-promyelocytic-leukemia-a-single-center-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:00:19Z","timestamp":1753916419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386763-assessing-the-impact-of-all-trans-retinoic-acid-atra--and-arsenic-trioxide-ato-based-therapy-in-pediatric-acute-promyelocytic-leukemia-a-single-center-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.89081","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}